Can kidney cancer be cured without surgery, and why can early stage kidney cancer be cured?

Patients with early-stage cancer can already achieve the highest possible rate, but it needs to be determined according to the specific situation of each patient, and the rate is different. After surgery, through the use of chemoradiotherapy and cellular immunity** to further control and prevent**, no matter what method is used, the main focus is to control the disease, improve symptoms, and prolong life.

Kidney cancer is a common malignant tumor of the urinary system, and the pathological type of the disease is generally clear cell carcinoma, which can have no symptoms in the early stage, and with the progression of the tumor, hematuria and other manifestations can occur, and metastasis of other organs can occur through lymphatic circulation, blood circulation and other pathways. The condition varies greatly from patient to patient, and the specific survival time cannot be determined, and surgery should be considered if surgery is indicated**.

Surgery is the first of choice for localized kidney cancer. Sexual nephrectomy surgery is a well-established possible method for kidney cancer. The preferred method for patients with locally advanced renal cancer is nephrectomy, and for metastatic lymph nodes or vascular thrombosis, it is necessary to choose whether to resect or not according to the degree of lesions, the patient's physical condition and other factors.

Metastatic kidney cancer should be treated with a comprehensive **. There is no standard protocol for metastatic kidney cancer. Surgery is an adjunct, and a very small number of patients can achieve long-term survival through surgery.

There are two main reasons for the high rate of early-stage kidney cancer: one is because it is early; The other is kidney cancer. First of all, it should be explained that no matter what kind of tumor it is, after early detection, the ** rate will be higher than that of advanced stage.

Because the tumor is not easy to treat, to what extent it can be treated, is mainly related to the stage, and the size of the tumor is obviously related, the earlier the staging indicates that the tumor is relatively small, the less invasive behavior occurs, and there is less possibility of distant metastasis. If there is no metastasis and the tumor is relatively small, it is certain that the malignant cells can be basically removed after surgery, and it is unlikely that there will be residual tumor lesions, so the ** rate is high.

Secondly, for another reason, it is kidney cancer, which is a tumor with a relatively good prognosis among various malignant tumors, with slower growth and later metastasis, so there are few other distant lesions in the early stage. Only a few types, such as sarcomatoid carcinoma or poorly differentiated renal collecting duct carcinoma, may not have a good prognosis after the early stage, so it is mainly related to these two factors.

Surgery is the first of choice for localized kidney cancer. Sexual nephrectomy surgery is a well-established possible method for kidney cancer. Early:

The patient's tumor was T1A, and the selective T1B and T2A were suitable for nephrectomy. Unilateral small tumors are operated on the principle of nephron-sparing surgery (partial nephrectomy) for unilateral small tumors (patients with tumors in T1A and elective T1B or T2A), as well as patients with isolated kidneys, renal insufficiency, bilateral renal lesions, and familial renal cell carcinoma. Patients with early-stage kidney cancer who do not require surgery can be monitored closely, and energy ablation** has a higher local** rate than conventional surgery.

Sexual nephrectomy surgery is a well-established possible method for kidney cancer. Early: The patient's tumor is T1A, and selective T1B and T2A are suitable for nephrectomy. It can be combined with NK immune cell reinfusion.

Hello, according to your description, in general, the early stage of kidney cancer, then consider that there is a possibility of **, and the **rate is relatively high, it is recommended that the patient still needs to actively cooperate**, then the early stage of kidney cancer, it is recommended to have timely surgery**, and in the later stage, according to the pathological situation, see if further chemotherapy is needed for prevention**.

"How much is biology" This is the question that Mr. Liu from Anhui Province mentioned to the director of the biology center of Chongqing Cancer Hospital in the consultation, and the professor made the following detailed answers to Mr. Liu's questions.

With the increasing incidence of kidney cancer, various methods of kidney cancer have emerged, surgery is one of the traditional and effective methods of kidney cancer, but after surgery due to incomplete resection, it often occurs. The disadvantage of surgery for kidney cancer is that it is not complete, and chemotherapy and radiotherapy are usually required as a follow-up after surgery.

Chemoradiotherapy can effectively remove the residual cancer cells in the patient's body, but the toxicity of chemoradiotherapy to other functions of the human body is also huge, the common ones are decreased immunity, digestive disorders, nervous system toxins, various organ toxins, etc., often make patients unbearable, have to give up, and excessive chemoradiotherapy will only speed up the death of patients.

Biological immunity** is a kind of "patient-friendly" after kidney cancer surgery, which can effectively kill and inhibit the growth of cancer cells through biological immune therapy, directly restore and improve human immune function, and enhance immunity to cancer to achieve therapeutic effect. Therefore, biological cellular immunity has a positive effect on consolidating the effect of preventing, delaying, and reducing cancer** and metastasis.

What is the cost of biology after kidney cancer resection Regarding the cost of biology after kidney cancer resection, as far as the biology center of Chongqing Cancer Hospital is concerned, a course of biology is about 14 days, about 10,000 yuan. Generally, a course of treatment in the early stage will have obvious clinical efficacy, and whether the second course of treatment is needed in the future, etc., clinical experts need to analyze and guide according to the specific situation of the patient, and if necessary, the second course of treatment will be done after 3-6 months.

Since its establishment, the Biological Center of Chongqing Cancer Hospital has always adhered to the path of "suitable development and innovative development", adhered to the principle of "people-oriented, medical care, treatment promotion, combination of treatment and treatment, independent innovation, quality first, and characteristics to win", and adopted the innovation strategy of "gathering advantages, advancing with cooperation, sharing resources, and improving as a whole", and taking the improvement of medical technology, medical quality, and convenient medical treatment as the core of hospital construction, so as to ensure that patients can seek medical treatment efficiently and build characteristic specialties. A series of measures such as convenient diagnosis and treatment have promoted the in-depth development of hospital tumor biology research, improved the quality of hospital technology and services, and provided the most comprehensive, high-quality and trustworthy health services. The Biology Center of Chongqing Cancer Hospital brings new hope to the majority of cancer patients with exquisite medical technology, authoritative departments and professional medical team.